San Francisco, California, March 06, 2017: TMR Research has published a new report titled, “Nuclear Medicine Equipment Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017 – 2025.” According to the report, technological evolutions which has resulted into hybrid imaging and improvements in the molecular imaging has introduced new radio Pharmaceuticals for diagnosis of diseases as well as for the therapy. Nuclear medicine equipment enables non-invasive and unique approach at the cellular and molecular levels. This is something that is not possible with any other imaging procedure. Also, the rising awareness regarding chronic diseases create a heightened demand for early detection of diseases which in turn will drive the growth of the global nuclear medicine equipment market.
Get Sample Copy of this Report @
The report not only discusses the various factors helping the market to grow but also discusses the factors which are anticipated to obstruct the growth of the market. One of the key factors acting as a challenge or roadblock for the global nuclear medicine equipment market is the lack of anatomic and molecular imaging training. The insufficient data or evidence which supports the capability of nuclear medicines would also be a challenge. The high cost of nuclear medicine equipment will also add option. In addition to this, unfavourable reimbursement policies in some areas of the world might also restrict the growth of the global nuclear medicine equipment market. On a bright note however, global players within the nuclear medicine equipment market are expected to gain from rising acceptance levels of advanced technology and a dire need for early detection of diseases.
On the basis of geography, the global nuclear medicine equipment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Of these, North America has been leading in the market for nuclear medicine equipment on account of the adoption of technological advancements at an early stage and the rapid development of novel radiopharmaceuticals for diagnosis and therapeutics. The Asia Pacific nuclear medicine equipment market is also witnessing a fast growth, with Japan in the forefront. The rising number of hybrid SPECT/CT examinations in Asia Pacific is anticipated to be a key factor driving the growth of the nuclear medicine equipment market. Countries such as India and China are increasingly demanding diagnosis and treatment of Alzheimer’s disease and Parkinson’s disease which in turn will also benefit the market for nuclear medicine equipment.
The report profiles key players within the global nuclear medicine equipment market such as Philips Healthcare, Siemens Healthineers, GE Healthcare, DDD-Diagnostics A/S, and Digirad Corporation. The strategies for expansion adopted by these companies and their recent developments have been mentioned in the report. The report also discusses the business and financial overview of the companies. The information regarding strategic alliances such as collaborations, mergers and acquisitions, partnerships, and joint ventures has been included in the report.